1.69
Tiziana Life Sciences Ltd stock is traded at $1.69, with a volume of 653.90K.
It is down -5.59% in the last 24 hours and down -24.04% over the past month.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
See More
Previous Close:
$1.79
Open:
$1.86
24h Volume:
653.90K
Relative Volume:
1.95
Market Cap:
$197.47M
Revenue:
-
Net Income/Loss:
$-13.73M
P/E Ratio:
-13.00
EPS:
-0.13
Net Cash Flow:
$-3.92M
1W Performance:
+1.81%
1M Performance:
-24.04%
6M Performance:
+18.18%
1Y Performance:
+82.05%
Tiziana Life Sciences Ltd Stock (TLSA) Company Profile
Name
Tiziana Life Sciences Ltd
Sector
Industry
Phone
-
Address
-
Compare TLSA with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
TLSA
Tiziana Life Sciences Ltd
|
1.69 | 203.32M | 0 | -13.73M | -3.92M | -0.13 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tiziana Life Sciences Ltd Stock (TLSA) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Dec-22-20 | Initiated | B. Riley Securities | Buy |
Dec-17-18 | Initiated | Laidlaw | Buy |
Tiziana Life Sciences Ltd Stock (TLSA) Latest News
Is Tiziana Life Sciences Ltd reversing from oversold territoryJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser
Tiziana Life Sciences Ltd stock outlook for YEARMarket Risk Analysis & Safe Capital Growth Trade Ideas - Newser
Does Tiziana Life Sciences Ltd qualify in momentum factor screeningMarket Growth Summary & Stock Portfolio Risk Control - Newser
How sentiment analysis helps forecast Tiziana Life Sciences LtdJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - Newser
What candlestick patterns are forming on Tiziana Life Sciences LtdShort Setup & Safe Entry Momentum Stock Tips - Newser
What earnings revisions data tells us about Tiziana Life Sciences LtdMarket Sentiment Review & Entry Point Confirmation Signals - Newser
How to build a dashboard for Tiziana Life Sciences Ltd stockJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
Risk vs reward if holding onto Tiziana Life Sciences Ltd2025 Trading Recap & Weekly Watchlist for Hot Stocks - Newser
Visualizing Tiziana Life Sciences Ltd stock with heatmapsJuly 2025 Spike Watch & High Yield Stock Recommendations - Newser
Using AI based signals to follow Tiziana Life Sciences LtdWeekly Investment Report & Growth Oriented Trading Recommendations - Newser
Tiziana Life Sciences Ltd stock momentum explained2025 Retail Activity & Stepwise Trade Signal Implementation - Newser
Pattern recognition hints at Tiziana Life Sciences Ltd upsideOil Prices & Target Return Focused Stock Picks - Newser
Using flow based indicators on Tiziana Life Sciences LtdTrade Volume Summary & Fast Exit and Entry Trade Guides - Newser
Will Tiziana Life Sciences Ltd bounce back from current supportWeekly Market Report & High Accuracy Investment Signals - Newser
Published on: 2025-09-12 03:59:09 - Newser
Smart tools for monitoring Tiziana Life Sciences Ltd’s price actionTrade Ideas & Daily Price Action Insights - Newser
Using Python tools to backtest Tiziana Life Sciences Ltd strategiesJuly 2025 Outlook & Fast Entry and Exit Trade Plans - Newser
Is Tiziana Life Sciences Ltd trending in predictive chart modelsJuly 2025 EndofMonth & Accurate Entry/Exit Alerts - Newser
Will Tiziana Life Sciences Ltd price bounce be sustainablePortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
how tiziana life sciences ltd stock performs during market volatilityMarket Sentiment Report & Free Low Drawdown Momentum Trade Ideas - Newser
Tiziana Life Sciences Ltd recovery potential after sell offWeekly Trend Report & Smart Swing Trading Alerts - Newser
Tick level data insight on Tiziana Life Sciences Ltd volatilityTrade Signal Summary & Growth Oriented Trading Recommendations - Newser
Institutional scanner results for Tiziana Life Sciences LtdJuly 2025 Outlook & Short-Term Trading Alerts - Newser
Does Tiziana Life Sciences Ltd fit your quant trading modelMarket Movement Recap & Risk Controlled Swing Trade Alerts - Newser
Key metrics from Tiziana Life Sciences Ltd’s quarterly data2025 Technical Overview & Stepwise Swing Trade Plans - Newser
Has Tiziana Life Sciences Ltd formed a bullish divergence2025 Breakouts & Breakdowns & Technical Confirmation Alerts - Newser
Health Care Stocks Move As Executive Decisions Stir The Sector - Finimize
Tiziana Life Sciences CEO buys 14,848 shares at $1.65 per share - Investing.com
Tiziana Life Sciences (TLSA) CEO Increases Stake in Company - GuruFocus
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer - The Manila Times
Tiziana Life Sciences CEO Ivor Elrifi Purchases 193,848 Shares of Common Stock at $1.65 Each - Quiver Quantitative
Tiziana Life Sciences Ltd Stock (TLSA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):